Art

J-GLOBAL ID：201002281986736419   Reference number：10A0858865

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

化学療法および放射線療法誘発悪心および嘔吐の予防におけるMASCCとESMOのガイドライン改訂 ペルージャ合意会議の結果

Author (23)： ROILA F. (S. Maria Univ. Hospital, Terni, ITA) ,  HERRSTEDT J. (Odense Univ. Hospital, Odense, DNK) ,  AAPRO M. (Inst. Multidisciplinaire d’Oncologie, Genolier, CHE) ,  GRALLA R. J. (Hofstra Univ. School of Medicine, Lake Success, USA) ,  EINHORN L. H. (Walther Cancer Inst., Indianapolis, USA) ,  BALLATORI E. (Medical Statistician, Spinetoli, ITA) ,  BRIA E. (Regina Elena National Cancer Inst., Rome, ITA) ,  CLARK-SNOW R. A. (Lawrence Memorial Hospital, Lawrence, USA) ,  ESPERSEN B. T. (Aarhus Univ. Hospital, Aarhus, DNK) ,  FEYER P. (Vivantes Clinics, Berlin-Neukoelln, Berlin, DEU) ,  GRUNBERG S. M. (Univ. Vermont, Burlington, USA) ,  HESKETH P. J. (Lahey Clinic, Burlington, USA) ,  JORDAN K. (Univ. Halle, Halle, DEU) ,  KRIS M. G. (Memorial Sloan-Kettering Cancer Center, New York, USA) ,  MARANZANO E. (S. Maria Univ. Hospital, Terni, ITA) ,  MOLASSIOTIS A. (Univ. Manchester, Manchester, GBR) ,  MORROW G. (Univ. Rochester Cancer Center, Rochester, USA) ,  OLVER I. (Cancer Council Australia, Sidney, AUS) ,  RAPOPORT B. L. (Medical Oncology Centre of Rosebank, Johannesburg, ZAF) ,  RITTENBERG C. (Rittenberg Oncology Consulting, Metairie, USA) ,  SAITO M. ,  TONATO M. ,  WARR D.
Material： Annals of Oncology  (Ann Oncol)
Volume： 21  Issue： Supplement 5  Page： V232-V243  Publication year： 2010 
JST Material Number： W0107A  ISSN： 0923-7534  CODEN： ANONE2  Document type： Article
Article type： 解説  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： drug therapy ,...
Semi thesaurus term： guideline

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0858865&from=J-GLOBAL&jstjournalNo=W0107A") }}

JST classification (4)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Radiotherapy for tumors  (GE03034K) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Clinical application of drugs acting on digestive system  (GW09020B)

Reference (34)：

• Roila F, Hesketh PJ, Herrstedt J et al. Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.
• Herrstedt J, Roila F. Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. Ann Oncol 2009; 20 (Suppl 4): 156-158.
• Kris MG, Hesketh PJ, Somerfield MR et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 2006; 24: 2932-2947.
• Hesketh PJ. Potential role of the NK1 receptor antagonists in chemotherapyinduced nausea and vomiting. Support Care Cancer 2001; 9: 350-354.
• Hesketh PJ, Grunberg SM, Gralla RJ et al. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - the Aprepitant Protocol 052 Study Group. J Clin Oncol 2003; 21: 4112-4119.

Terms in the title (11)： 化学療法 ,  放射線療法 ,  誘発 ,  悪心 ,  嘔吐 ,  予防 ,  ESMO ,  ガイドライン改訂 ,  ペルー ,  合意 ,  会議